An­oth­er Ra­maswamy stunt plays well on Wall Street, Mar­tin Shkre­li on shame, and more

End­points as­sess­es the big bio­phar­ma R&D sto­ries of the week, with a lit­tle added com­men­tary on what they mean for the in­dus­try.

Ra­maswamy strikes …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.